IM Cannabis

Company Overview

Snapshot

Founded in January 2008, IM Cannabis operates with 11–50 employees and has raised a total of $68 million across 14 funding rounds. The company has attracted 2 investors and in June 2026, it announced a letter of intent to sell its European activities, aiming to significantly reduce its debt.

Business overview

IM Cannabis is an international cannabis company specializing in providing premium medical cannabis products to patients in key markets such as Israel and Germany. The company leverages a data-driven approach and a globally sourced product supply chain to serve the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology and Medical Cannabis categories.

Strategic signal

In March 2026, IM Cannabis announced a strategic entry into the cyber drone interception and satellite intelligence markets by signing a non-binding agreement to acquire a 51% stake in Blackaxe Technologies. This move signals a significant strategic pivot for the company, diversifying its operations beyond medical cannabis into high-tech defense and intelligence sectors, potentially opening new revenue streams and investor interest in a different market segment.

Company Intelligence Q&A

What was the most recent funding activity for IM Cannabis?

In June 2026, IM Cannabis raised US$225,000 of gross proceeds in convertible note financing.

What strategic decision did IM Cannabis announce regarding its European operations?

In June 2026, IM Cannabis Corp. entered into a Letter of Intent to sell its European activities, with an expectation to significantly reduce debt by CAD$10.5 million.

What was IM Cannabis's financial performance in the first quarter of 2026?

IM Cannabis Corp. announced its First Quarter 2026 Financial Results in May 2026.

Did IM Cannabis make any acquisitions recently?

In March 2026, IM Cannabis announced a strategic entry into the cyber drone interception and satellite intelligence markets by signing a non-binding agreement to acquire 51% of Blackaxe Technologies.

What were IM Cannabis's financial results for the full year 2025?

In March 2026, IM Cannabis reported 2025 results, including revenue of C$54.7 million with over 134% growth in Germany and positive operating cash flow.